Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Morphometric analysis of vascular pathology in the orbitofrontal cortex of older subjects with major depression.

Miguel-Hidalgo JJ, Jiang W, Konick L, Overholser JC, Jurjus GJ, Stockmeier CA, Steffens DC, Krishnan KR, Rajkowska G.

Int J Geriatr Psychiatry. 2013 Sep;28(9):959-70. doi: 10.1002/gps.3911. Epub 2012 Dec 3.

2.

Coverage of blood vessels by astrocytic endfeet is reduced in major depressive disorder.

Rajkowska G, Hughes J, Stockmeier CA, Javier Miguel-Hidalgo J, Maciag D.

Biol Psychiatry. 2013 Apr 1;73(7):613-21. doi: 10.1016/j.biopsych.2012.09.024. Epub 2012 Nov 10.

3.

Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes.

Miguel-Hidalgo JJ, Overholser JC, Jurjus GJ, Meltzer HY, Dieter L, Konick L, Stockmeier CA, Rajkowska G.

J Affect Disord. 2011 Aug;132(3):422-31. doi: 10.1016/j.jad.2011.03.052. Epub 2011 May 4.

4.

Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression.

Khundakar A, Morris C, Oakley A, McMeekin W, Thomas AJ.

Br J Psychiatry. 2009 Aug;195(2):163-9. doi: 10.1192/bjp.bp.108.052688.

5.

Gray matter volume and rapid decision-making in major depressive disorder.

Nakano M, Matsuo K, Nakashima M, Matsubara T, Harada K, Egashira K, Masaki H, Takahashi K, Watanabe Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:51-6. doi: 10.1016/j.pnpbp.2013.09.011. Epub 2013 Sep 25.

PMID:
24076064
6.

White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies.

Tham MW, Woon PS, Sum MY, Lee TS, Sim K.

J Affect Disord. 2011 Jul;132(1-2):26-36. doi: 10.1016/j.jad.2010.09.013. Epub 2010 Oct 2. Review.

PMID:
20889213
7.

Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder.

Salvadore G, Nugent AC, Lemaitre H, Luckenbaugh DA, Tinsley R, Cannon DM, Neumeister A, Zarate CA Jr, Drevets WC.

Neuroimage. 2011 Feb 14;54(4):2643-51. doi: 10.1016/j.neuroimage.2010.11.011. Epub 2010 Nov 10.

8.

Regional brain volume in depression and anxiety disorders.

van Tol MJ, van der Wee NJ, van den Heuvel OA, Nielen MM, Demenescu LR, Aleman A, Renken R, van Buchem MA, Zitman FG, Veltman DJ.

Arch Gen Psychiatry. 2010 Oct;67(10):1002-11. doi: 10.1001/archgenpsychiatry.2010.121.

PMID:
20921116
9.

Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder.

Miguel-Hidalgo JJ, Baucom C, Dilley G, Overholser JC, Meltzer HY, Stockmeier CA, Rajkowska G.

Biol Psychiatry. 2000 Oct 15;48(8):861-73.

PMID:
11063981
10.

A morphometric examination of neuronal and glial cell pathology in the orbitofrontal cortex in late-life depression.

Khundakar A, Morris C, Oakley A, Thomas AJ.

Int Psychogeriatr. 2011 Feb;23(1):132-40. doi: 10.1017/S1041610210000700. Epub 2010 Jun 18.

PMID:
20561380
11.

Gender-specific decrease in NUDR and 5-HT1A receptor proteins in the prefrontal cortex of subjects with major depressive disorder.

Szewczyk B, Albert PR, Burns AM, Czesak M, Overholser JC, Jurjus GJ, Meltzer HY, Konick LC, Dieter L, Herbst N, May W, Rajkowska G, Stockmeier CA, Austin MC.

Int J Neuropsychopharmacol. 2009 Mar;12(2):155-68. doi: 10.1017/S1461145708009012. Epub 2008 Jun 19.

12.

Unchanged packing density but altered size of neurofilament immunoreactive neurons in the prefrontal cortex in schizophrenia and major depression.

Miguel-Hidalgo JJ, Dubey P, Shao Q, Stockmeier C, Rajkowska G.

Schizophr Res. 2005 Jul 15;76(2-3):159-71.

13.

Reduced connexin 43 immunolabeling in the orbitofrontal cortex in alcohol dependence and depression.

Miguel-Hidalgo JJ, Wilson BA, Hussain S, Meshram A, Rajkowska G, Stockmeier CA.

J Psychiatr Res. 2014 Aug;55:101-9. doi: 10.1016/j.jpsychires.2014.04.007. Epub 2014 Apr 16.

14.

Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder.

Miguel-Hidalgo JJ, Whittom A, Villarreal A, Soni M, Meshram A, Pickett JC, Rajkowska G, Stockmeier CA.

J Affect Disord. 2014 Apr;158:62-70. doi: 10.1016/j.jad.2014.02.010. Epub 2014 Feb 10.

15.

Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression.

Benedetti F, Radaelli D, Poletti S, Locatelli C, Falini A, Colombo C, Smeraldi E.

J Affect Disord. 2011 Dec;135(1-3):139-47. doi: 10.1016/j.jad.2011.07.006. Epub 2011 Jul 31.

PMID:
21807414
16.

Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study.

Davis S, Thomas A, Perry R, Oakley A, Kalaria RN, O'Brien JT.

J Neurol Neurosurg Psychiatry. 2002 Nov;73(5):556-60.

17.

Morphometric changes in early- and late-life major depressive disorder: evidence from postmortem studies.

Khundakar AA, Thomas AJ.

Int Psychogeriatr. 2009 Oct;21(5):844-54. doi: 10.1017/S104161020999007X. Epub 2009 Jun 22.

PMID:
19538828
18.

Widespread reductions in gray matter volume in depression.

Grieve SM, Korgaonkar MS, Koslow SH, Gordon E, Williams LM.

Neuroimage Clin. 2013 Sep 6;3:332-9. doi: 10.1016/j.nicl.2013.08.016. eCollection 2013.

19.

Age-dependent reductions in the level of glial fibrillary acidic protein in the prefrontal cortex in major depression.

Si X, Miguel-Hidalgo JJ, O'Dwyer G, Stockmeier CA, Rajkowska G.

Neuropsychopharmacology. 2004 Nov;29(11):2088-96.

20.

Is there an association between peripheral immune markers and structural/functional neuroimaging findings?

Frodl T, Amico F.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:295-303. doi: 10.1016/j.pnpbp.2012.12.013. Epub 2013 Jan 11. Review.

PMID:
23313563
Items per page

Supplemental Content

Write to the Help Desk